News Articles and Montana BioScience Alliance Newsletters

TIME has revealed its annual list of the Best Inventions, which features 200 extraordinary innovations changing our lives. GRAIL’s Galleri® test was one of the 200 innovations. The Galleri test is a multi-cancer early detection (MCED) test that can detect a shared cancer signal across more than 50 types of cancer through a simple blood draw.

Central Montana has produced a star in the field of chemistry. Erin Baker, the daughter of Alan and Stephanie Shammel of Hilger and now a Professor of Chemistry at the University of North Carolina, has won several awards for her contributions to the field this year. 

For a fourth straight year, Montana State University recorded an all-time high for research expenditures, which support scientific discovery, rural outreach and a variety of scholastic pursuits, as well as providing hands-on opportunities for students to engage in science and creative activities that build skills for careers after they earn their degrees

In Montana we rally and circle the wagons when a member of our community is suffering, with everyone lending a hand. Our own Senator Jon Tester has demonstrated this truly Montana trait by working to advance policy changes that must occur to alter the course of cancer detection and treatment.

Solo-Dex has announced an exclusive Product Distribution Agreement for Solo-Dex Fascile® suite of products with CH Trading Group LLC, an international import, export and trading company. The Agreement focuses on the MENA regional markets and extends the availability of Solo-Dex Fascile products beyond the U.S., Europe and Brazil to dozens of countries, including those that are part of the Gulf Cooperation Council, the African Union and the Organization of Islamic Cooperation.

When her husband was undergoing cancer treatment, Cindy Perez of Southwest Ranches, Fla., learned about a new blood test that could help find early cancers. The 50-year-old said she felt fine, but her husband urged her to take the test anyway.

Studies of interactions between two lab-generated monoclonal antibodies (mAbs) and an essential Epstein-Barr virus (EBV) protein have uncovered targets that could be exploited in designing treatments and vaccines for this extremely common virus.

As a new year begins in Congress, the Biotechnology Innovation Organization (BIO) is carrying over many of its legislative priorities from last year.

Administrative Supplements to Promote Diversity in Research and Development Small Businesses – SBIR/STTR

Contract Pre-solicitation for R&D that will contribute toward ARPA-H mission needs and SBIR program objectives.

View the Spring 2024 Newsletter now!

View the Winter II 2024 Newsletter now!